Aura Biosciences logo

Aura Biosciences

AURA | NASDAQ
Chart Builder DCF Calculator
$7.22
+$0.11 (+1.55%)
At close: Nov 16, 2026, 4:00 PM ET
$7.22
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET
+1.55%

Rating

Updated: Nov 16, 2026
27
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #874/1021 (Top 86%)

Key Statistics

Market Data

Market Cap $801.95M
1D Range
7.00 7.30
52W Range
4.97 8.90

Valuation (TTM)

PE -4.32
PB 2.79
EV/EBITDA -3.69

Valuation (NTM)

Forward PE N/A
Forward PEG 0.19
Price Target $16.50
Loading financial charts...

Profile

Headquartered in Cambridge, Massachusetts, Aura Biosciences, Inc. is a biotechnology firm established in 2009 that specializes in pioneering cancer treatments. The company leverages its proprietary vi...

Sector Healthcare
Industry Biotechnology
Employees 113
IPO Date Oct 29, 2021
Fiscal Year January - December

Latest News

No news articles available yet.

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$16.50
Upside
+128.53%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.